Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Tóm tắt
Từ khóa
Tài liệu tham khảo
Schmid, 2009, Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study, Lancet, 374, 48, 10.1016/S0140-6736(09)60618-8
Hou, 2008, Changes of clinical features in hydatidiform mole: analysis of 113 cases, J Reprod Med, 53, 629
Fowler, 2007, Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examination, Ultrasound Obstet Gynecol, 29, 76, 10.1002/uog.3880
Hinshaw, 2006, The management of early pregnancy loss
Seckl, 2004, Routine terminations of pregnancy-should we screen for gestational trophoblastic neoplasia, Lancet, 364, 705, 10.1016/S0140-6736(04)16898-0
Sebire, 2002, Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin, Lancet, 359, 2165, 10.1016/S0140-6736(02)09085-2
Fisher, 2007, The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies, Gynecol Oncol, 107, 413, 10.1016/j.ygyno.2007.07.081
Sebire, 2010, Immunohistochemical staining for diagnosis and prognostic assessment of hydatidiform moles: current evidence and future directions, J Reprod Med, 55, 236
Sebire, 2013, Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations, Placenta, 34, 50, 10.1016/j.placenta.2012.11.005
Shih, 1998, Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma, Am J Surg Pathol, 22, 1393, 10.1097/00000478-199811000-00010
Sebire, 2007, Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit, BJOG, 114, 760, 10.1111/j.1471-0528.2007.01320.x
Kohorn, 2002, Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report, J Reprod Med, 47, 445
Agarwal, 2012, Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study, Lancet, 379, 130, 10.1016/S0140-6736(11)61265-8
Agarwal, 2012, Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia, Br J Cancer, 106, 1089, 10.1038/bjc.2012.65
Berkowitz, 2009, Current management of gestational trophoblastic diseases, Gynecol Oncol, 112, 654, 10.1016/j.ygyno.2008.09.005
Darby, 2009, Does chest CT matter in the staging of GTN?, Gynecol Oncol, 112, 155, 10.1016/j.ygyno.2008.10.003
FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. International Journal of Gynecology & Obstetrics 77:285-287.
Alazzam, 2009, First line chemotherapy in low risk gestational trophoblastic neoplasia, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD007102.pub2
Kohorn, 2002, Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?, Gynecol Oncol, 85, 36, 10.1006/gyno.2001.6533
Osborne, 2011, Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study, J Clin Oncol, 29, 825, 10.1200/JCO.2010.30.4386
Lurain, 2012, Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia, J Reprod Med, 57, 283
McNeish, 2002, Low risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid, 1992 to 2000, J Clin Oncol, 20, 1838, 10.1200/JCO.2002.07.166
Sita-Lumsden, 2012, Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009, Br J Cancer, 107, 1810, 10.1038/bjc.2012.462
Lybol, 2012, Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia, Gynecol Oncol, 125, 576, 10.1016/j.ygyno.2012.03.003
McGrath, 2010, The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1), Br J Cancer, 102, 810, 10.1038/sj.bjc.6605529
van Trommel, 2006, Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease, J Clin Oncol, 24, 52, 10.1200/JCO.2005.03.3043
You, 2013, Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements, Br J Cancer, 108, 1810, 10.1038/bjc.2013.123
Deng, 2009, Combination chemotherapy for high-risk gestational trophoblastic tumour, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD005196.pub3
Kim, 1998, Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT—25 years experiences of KRI-TRD, Int J Gynaecol Obstet, 60, S85, 10.1016/S0020-7292(98)80010-6
Bower, 1997, EMA/CO for high-risk gestational trophoblastic tumours: results from a cohort of 272 patients, J Clin Oncol, 15, 2636, 10.1200/JCO.1997.15.7.2636
Turan, 2006, Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia, Int J Gynecol Cancer, 16, 1432, 10.1136/ijgc-00009577-200605000-00074
Newlands, 2002, Management of brain metastases in patients with high-risk gestational trophoblastic tumors, J Reprod Med, 47, 465
Ahamed, 2012, Survival of women with gestational trophoblastic neoplasia and liver metastases: is it improving?, J Reprod Med, 57, 262
Alifrangis, 2013, EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis, J Clin Oncol, 31, 280, 10.1200/JCO.2012.43.1817
Seckl, 2009, Investigation and treatment of patients with persistent gestational trophoblastic disease and gestational trophoblastic tumours/neoplasia in the United Kingdom, 335
Lybol, 2012, Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy, Ann Oncol, 23, 2903, 10.1093/annonc/mds199
Dhillon, 2006, Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia, J Reprod Med, 51, 879
Lurain, 2005, Secondary chemotherapy for high-risk gestational trophoblastic neoplasia, Gynecol Oncol, 97, 618, 10.1016/j.ygyno.2005.02.004
Jones, 1996, Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases, Gynecol Oncol, 61, 126, 10.1006/gyno.1996.0110
Osborne, 2004, Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet, J Reprod Med, 49, 655
Termrungruanglert, 1996, Remission of refractory gestational trophoblastic disease with high-dose paclitaxel, Anticancer Drugs, 7, 503, 10.1097/00001813-199607000-00001
Wang, 2008, Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE), Ann Oncol, 19, 1578, 10.1093/annonc/mdn181
Pandian, 2004, Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery, BJOG, 111, 382, 10.1111/j.1471-0528.2004.00065x.x
Bianconi, 2007, Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine, Gynecol Oncol, 106, 268, 10.1016/j.ygyno.2007.04.002
El-Helw, 2005, High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia, Br J Cancer, 93, 620, 10.1038/sj.bjc.6602771
Palmieri, 2005, Placental site trophoblastic tumour arising from a partial hydatidiform mole, Lancet, 366, 688, 10.1016/S0140-6736(05)67143-7
Cole, 2006, Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors, Gynecol Oncol, 102, 160, 10.1016/j.ygyno.2005.12.046
Harvey, 2008, Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors, J Reprod Med, 53, 643
Pfeffer, 2007, Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour, Lancet Oncol, 8, 744, 10.1016/S1470-2045(07)70243-7
The ISSTD global Placental Site Trophoblastic Tumour database. International Society of the Study of Trophoblastic Diseases. https://pstt.shef.ac.uk.